TCF7L2 Recombinant Monoclonal Antibody

說明書

中文名稱：

TCF7L2 Recombinant Monoclonal Antibody
貨號：

CSB-RA192658A0HU
規格：

￥1320
圖片：
Immunofluorescence staining of Hela cell with CSB-RA192658A0HU at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).

Overlay Peak curve showing A549 cells stained with CSB-RA192658A0HU (red line) at 1:100. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100 for?10min. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10⁶cells) for 45min at 4℃. The secondary antibody used was FITC-conjugated goat anti-rabbit IgG (H+L) at 1/200 dilution for 35min at 4℃.Control antibody (green line) was Rabbit IgG (1ug/1*10⁶cells) used under the same conditions. Acquisition of >10,000 events was performed.
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

Q9NQB0
基因名：

TCF7L2
別名：

HMG box transcription factor 4 antibody; hTCF 4 antibody; hTCF-4 antibody; T cell factor 4 antibody; T cell specific HMG box antibody; T cell specific transcription factor 4 antibody; T-cell factor 4 antibody; T-cell-specific transcription factor 4 antibody; TCF 4 antibody; TCF-4 antibody; TCF4 antibody; TCF7L2 antibody; TCF7L2 protein antibody; TF7L2_HUMAN antibody; Transcription factor 7 like 2 antibody; Transcription factor 7 like 2 T cell specific HMG box antibody; Transcription factor 7-like 2 antibody
反應種屬：

Human
免疫原：

A synthesized peptide derived from human TCF7L2
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

Rabbit IgG
純化方式：

Affinity-chromatography
克隆號：

13G5
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
產品提供形式：

Liquid
應用范圍：

ELISA, IF, FC

推薦稀釋比：

Application	Recommended Dilution
IF	1:50-1:200
FC	1:50-1:200

Protocols：

ELISA Protocol
Immunofluorescence (IF) Protocol
Flow cytometry (FC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Participates in the Wnt signaling pathway and modulates MYC expression by binding to its promoter in a sequence-specific manner. Acts as repressor in the absence of CTNNB1, and as activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine.
基因功能參考文獻：
1. Studied association of single nucleotide polymorphisms in Transcription factor 7-like 2 (TCF7L2) gene and genetic predisposition to type 2 diabetes in nonobese patients. PMID: 28263491
2. The meta-analysis suggested that TCF7L2 polymorphism rs7903146 was significantly associated with type 2 diabetes mellitus in Caucasian, East Asian, South Asian and other ethnicities. [Meta-analysis] PMID: 29514658
3. The responses of insulin and HOMA-IR to ALE supplementation have shown an interaction with single-nucleotide polymorphism rs7903146 in TCF7L2. PMID: 30177026
4. The two varients of the gene TCF7L2 are important genetic risk factors for the T2D development in the Han ethnic group in China. PMID: 30266127
5. In conclusion, homozygous TT allele carriers show altered postprandial triglyceride response, mainly influencing very low density lipoproteins and high density lipoproteins subclasses suggesting a genotype-mediated effect on hepatic lipid regulation. PMID: 28220878
6. a considerable connection of DEFB1 and TCF7L2 gene polymorphisms with nephrolithiasis PMID: 29959006
7. stable knockdown of FOXO3, NCOA3, and TCF7L2 restored growth in low glucose but reduced MEK/MAPK phosphorylation, reduced anchorage-independent growth, and modulated expressions of GLUT1 and Ras pathway related proteins. PMID: 29301589
8. Study showed the association of TCF7L2 SNPs (rs7903146, rs12255372, and rs10885406) with high total cholesterol/high-density lipoproteins ratio. Findings highlight the influence of TCF7L2 SNPs on altered lipid profile in the Balinese, which may further link to the risk of cardiovascular diseases. PMID: 30027476
9. TCF7L2 rs7903146 polymorphism may be associated with the susceptibility to diabetic nephropathy in Chinese Han population, but rs290487 is not. The strong linkage disequilibrium existed between the 2 single nucleotide polymorphisms and haplotype T-T (rs7903146-rs290487) increased the susceptibility to diabetic nephropathy. PMID: 30290587
10. the T risk allele of the rs7903146 in the TCF7L2 gene increases the risk of type 2 diabetes, was determined. PMID: 29631902
11. Common variation at TCF7L2 influences acute responses to both glipizide and metformin in people without diabetes and highlight altered incretin signaling as a potential mechanism by which TCF7L2 variation increases T2D risk. PMID: 29326107
12. No correlation between the studied polymorphisms of the TCF7L2 gene and GDM was observed. PMID: 27958632
13. Type 1 diabetes mellitus patients carriers of the TCF7L2 variant had a milder immunologic and metabolic phenotype at type 1 diabetes diagnosis, which could be partly driven by type 2 diabetes-like pathogenic mechanisms. PMID: 29025879
14. The SNPs in TCF7L2 and HHEX were genotyped by polymerase chain reaction-restriction fragment length polymorphism. There were no significant differences in the distribution of genotypes and alleles between polycystic ovary syndrome cases and controls PMID: 26563606
15. rs122555372 was associated with pancreatic reserve in patients with type 2 diabetes and with fasting glucose and beta-cell function in individuals without diabetes PMID: 28101933
16. TCF7L2 mRNA expression is downregulated in humans with impaired glucose tolerance and adipocyte insulin resistance. PMID: 29317436
17. PGC-1alpha induction during differentiation is required for both mitochondrial biogenesis and commitment to the hepatocytic lineage, and TCF7L2 repression is sufficient to increase PGC-1alpha expression, mitochondrial biogenesis and OXPHOS activity. PMID: 28795454
18. role in dermal papilla cell proliferation PMID: 24354472
19. Silencing the tcf4 gene confers sensitivity to oxaliplatin in colorectal cancer cells. PMID: 24869759
20. GRbeta bound to the N-terminus domain of TCF-4 its influence on Wnt signaling required both ligand- and DNA-binding domains. This is enough to maintain the TCF/LEF activity at a high level in the absence of beta-catenin stabilization. PMID: 25301232
21. TRIB2 negatively regulates Wnt activity through a reduction in protein stability of TCF4 and beta-Catenin PMID: 25311538
22. CtBP physically interacted with TCF-4, and this interaction was significantly inhibited in the presence of MTOB. The above findings point to a novel role of CtBPs in the promotion of CSC growth and self-renewal PMID: 25483087
23. Our data revealed that low TCF4 protein expression was a useful predictive factor of good tumor response to nCRT and good outcomes in patients with LARC. PMID: 25519018
24. These results indicate that a dynamic interplay of TCF transcription factors governs MYC gene expression in colorectal cancers. PMID: 25659031
25. KLF5 facilitates lysophosphatidic acid -induced interaction between beta-catenin and TCF4. PMID: 25683913
26. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated beta-catenin by sequestering TCF4 to the nuclear membrane. PMID: 26350900
27. Results provides evidence that TCF4 and ZEB1 modulate each other's transcriptional activity in the regulation of tumor pro-invasive Wnt target genes. PMID: 26387539
28. The expression of NLK was negatively correlated with TCF4 expression in lung cancers PMID: 26823848
29. the beta-catenin/Tcf4 interaction is disrupted by BC-23 PMID: 27014877
30. Data show that HMG-box transcription factor 1 protein HBP1-mediated elevation of CDK inhibitor p21 through the Mdm2/p53 and TCF4/EZH2 pathways contributes to both cellular senescence and tumor inhibition. PMID: 27129219
31. These results may provide a linkage between PCa chemoresistance and exosome regulatory networks and thus lead us to propose that AR, PTEN and TCF4 genes may be the important genes which are regulated by exosome miRNAs in chemoresistance cancer cells. PMID: 27278879
32. G-17 caused the overexpression of beta-catenin and TCF-4. PMID: 27430592
33. Taken together, these results suggest that this newly identified Rock2-beta-catenin/TCF4-SCARA5 axis will provide novel insight into the understanding of the regulatory mechanisms of proliferation in human RCC. PMID: 27793664
34. we observed Dickkopf-related protein 3 (DKK3) as a direct target of miR-25 in vitro. Upregulation of DKK3 partially attenuated the oncogenic effect of miR-25 on melanoma cells. Ectopic expression of miR-25 in melanoma cells induced beta-catenin accumulation in nuclear and inhibited TCF4 (T cell factor 4) activity, as well as the expression of c-Myc and Cyclin D1. PMID: 27801786
35. FOXN3 bind to beta-catenin and inhibited beta-catenin/TCF signaling by blocking the interaction between beta-catenin and TCF4. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells. PMID: 28039460
36. High TCF4 expression is associated with colorectal cancer. PMID: 28921929
37. Overexpression of vPK led to reduced mRNA expression of cyclin D1, a well-known transcriptional product of Wnt signaling, suggesting that vPK effectively regulates the host signaling pathway through direct interactions with cellular proteins. PMID: 29432739
38. TCF7L2 rs290487, rs6585194, and rs7094463 polymorphisms were found to be significantly associated with gestational diabetes mellitus. PMID: 27465520
39. TCF7L2 rs7903146 polymorphism is associated with ischemic heart disease. PMID: 28299838
40. The IVS3C>T locus in the TCF7L2 gene is not independently statistically significantly associated with the development of type 2 Diabetes Mellitus in the Kyrgyz population. PMID: 29171469
41. six of eight SNPs were found to have significant associations between TCF7L2 variants and gestational diabetes mellitus (GDM) risk in the overall population, with the most powerful SNPs being rs7903146, rs12255372 and rs7901695, but the contribution of these SNPs to GDM risk were variable among different racial/ethnic groups - meta-analysis PMID: 28002648
42. These results suggest rs12573128 is significantly associated with an increased risk of SCZ in the Chinese Han population. PMID: 28404897
43. The study found that TCF7L2 SNPs (rs1225404 and rs7003146) might be associated with breast cancer risk in Northwest Chinese Han populations. PMID: 27738320
44. These findings further support the hypothesis that TCF7L2 gene variation contributes to diabetogenesis in a subset of young people with Type 1 diabetes. PMID: 27027642
45. The rs7903146 variant in the TCF7L2 gene increases the risk of impaired glucose tolerance or type 2 diabetes in obese adolescents by impairing beta-cell function, and hepatic insulin sensitivity predicts the development of impaired glucose tolerance or type 2 diabetes over time. PMID: 28611053
46. In conclusion, TCF7L2 regulates estradiol- or progesterone-modulated islet and hepatic glucose metabolism. PMID: 27108846
47. TCF7L2 rs7903146 and 112/112 haplotype of CAPN10 might be associated with gestational diabetes risks.[meta-analysis] PMID: 28277135
48. Authors found that KIF23 was regulated by TCF-4 at transcriptionally level. Therefore, this evidence indicates KIF23 over-expression is associated with glioma malignancy and conferred a worse survival time in glioma. PMID: 27013586
49. findings indicate that the association between TCF7L2 SNP rs12255372 and HDL-C may be modified by dietary fat intake in this Asian Indian population PMID: 29182660
50. Wnt Signaling Pathway Effector TCF7L2 plays a role in Glucose Homeostasis. PMID: 27159876
顯示更多

收起更多
相關疾病：

Diabetes mellitus, non-insulin-dependent (NIDDM)
亞細胞定位：

Nucleus, PML body. Note=Diffuse pattern. Colocalizes with SUMO1 and PIAS4 in a subset of PML (promyelocytic leukemia) nuclear bodies.
蛋白家族：

TCF/LEF family
組織特異性：

Detected in epithelium from small intestine, with the highest expression at the top of the crypts and a gradient of expression from crypt to villus. Detected in colon epithelium and colon cancer, and in epithelium from mammary gland and carcinomas derived
數據庫鏈接：

HGNC: 11641

OMIM: 125853

KEGG: hsa:6934

STRING: 9606.ENSP00000444972

UniGene: Hs.593995

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human